key: cord-1017130-2zc00tgf authors: Geddes, Maiya R.; O'Connell, Megan E.; Fisk, John D.; Gauthier, Serge; Camicioli, Richard; Ismail, Zahinoor title: Remote cognitive and behavioral assessment: Report of the Alzheimer Society of Canada Task Force on dementia care best practices for COVID‐19 date: 2020-09-22 journal: Alzheimers Dement (Amst) DOI: 10.1002/dad2.12111 sha: 793ea245606465a5bad72be26afff0777994723f doc_id: 1017130 cord_uid: 2zc00tgf INTRODUCTION: Despite the urgent need for remote neurobehavioral assessment of individuals with cognitive impairment, guidance is lacking. Our goal is to provide a multi‐dimensional framework for remotely assessing cognitive, functional, behavioral, and physical aspects of people with cognitive impairment, along with ethical and technical considerations. METHODS: Literature review on remote cognitive assessment and multidisciplinary expert opinion from behavioral neurologists, neuropsychiatrists, neuropsychologists, and geriatricians was integrated under the auspices of the Alzheimer Society of Canada Task Force on Dementia Care Best Practices for COVID‐19. Telephone and video approaches to assessments were considered. RESULTS: Remote assessment is shown to be acceptable to patients and caregivers. Informed consent, informant history, and attention to privacy and autonomy are paramount. A range of screening and domain‐specific instruments are available for telephone or video assessment of cognition, function, and behavior. Some neuropsychological tests administered by videoconferencing show good agreement with in‐person assessment but still lack validation and norms. Aspects of the remote dementia‐focused neurological examination can be performed reliably. DISCUSSION: Despite challenges, current literature and practice support implementation of telemedicine assessments for patients with cognitive impairment. Convergence of data across the clinical interview, reliable and brief remote cognitive tests, and remote neurological exam increase confidence in clinical interpretation and diagnosis. telephone or video assessment of cognition, function, and behavior. Some neuropsychological tests administered by videoconferencing show good agreement with inperson assessment but still lack validation and norms. Aspects of the remote dementiafocused neurological examination can be performed reliably. Discussion: Despite challenges, current literature and practice support implementation of telemedicine assessments for patients with cognitive impairment. Convergence of data across the clinical interview, reliable and brief remote cognitive tests, and remote neurological exam increase confidence in clinical interpretation and diagnosis. Alzheimer's disease, assessment, cognitive impairment, dementia, telehealth, telemedicine There is a vital need for a framework to guide the remote cognitive and behavioral assessment of individuals with cognitive impairment. Cognitive impairment is an epidemic: Nearly one in three individuals over age 70 years lives with either mild cognitive impairment (MCI) or dementia. 1 Almost 50 million people live with dementia worldwide, 2 and this number is predicted to increase 161% by 2050. 3 This "dementia tsunami" has led to an urgent need for access to diagnostic assessment and care to minimize the burden on older adults, caregivers, healthcare systems, and society. The lack of access to specialty care may have the consequences of delayed or missed diagnoses, suboptimal symptom management, missed opportunities for lifestyle and other behavioral interventions, and increased risks to caregivers. Remote assessment and care may provide opportunities to mitigate some of these challenges. With the onset of the coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remote assessment of individuals with cognitive impairment is no longer a need only for those in rural communities or with travel and mobility limitations. The absence of proven SARS-CoV-2 vaccines and effective treatments led to public health strategies relying on preventative measures such as hand washing, mask wearing, and physical distancing, all of which substantially limit access to in-person clinical care and are particularly difficult to implement for frail individuals with cognitive impairment. 4 Underlying dementia, compared to other medical comorbidities, confers the greatest risk for contracting COVID-19 in adults over 65 years, while advanced age and cognitive impairment dramatically increase morbidity and mortality from COVID-19. 5 Thus remote assessment of cognition has immediately become an imperative for those attempting to provide care for this population. Rather than simply representing a cost-efficient alternative, remote assessment is an important means of protecting patients and their families from the unnecessary risk of exposure in hospitals. The Centers for Medicare & Medicaid Services defines "telemedicine" as the "two-way, real time interactive communica-tion between the patient and the physician or practitioner at [a] distant site." Current approaches to telemedicine include telephone calls or videoconferencing. Remote dementia care is accepted by families 6 and reduces emergency room visits. 7 These best practices provide guidance for the multi-dimensional assessment of cognition, behavior, and function in cognitively impaired individuals. In what follows we discuss ethical and technical considerations and then provide an overall framework for remote neurobehavioral assessment, including telephone and video-administration formats. We review specific assessment methods to obtain information on cognition, behavior, and function. In Supplementary Materials we provide guidance on administering a dementia-focused remote neurological examination. The same clinical and ethical standards that apply to in-person encounters also apply to the remote environment. Telemedicine has the potential benefits of enabling access to specialists among patients with reduced mobility and/or geographical constraints, and improved patient convenience and comfort. Potential pitfalls include a threat to patient privacy and confidentiality, limitations in clinical data acquisition, risks to quality and continuity of care, and the potentially negative impact of remote care on patient-clinician relationships. Although older adults are increasingly adept at using technology, age-related perceptual, language, and cognitive barriers must be considered. 8 In addition, it is important to consider how sociocultural and economic factors influence access to remote care and the interpretation of remote cognitive assessments. 8 Clinician and patient comfort and proficiency with technology, awareness of telehealth limitations, and judgement of when to shift to an in-person encounter are necessary to fulfill competency of care in telehealth. 9 Telemedicine should humanize both the provider and patient. In general, patients are satisfied with remote care. 6 In an analytic literature survey on remote physician-patient communication, non-verbal behavior and lack of touch were the only categories reported as unsatisfactory for patients. 10 During a telemedicine encounter, clinician empathy can be effectively communicated by maintaining eye contact, facial expression, empathetic gestures (e.g., head nods), voice, and attentiveness. 11 This is critical because clinician empathy is associated with positive health outcomes. 12 To achieve continuity of care, the clinician should be accessible for future guidance, create a medical record of the telemedicine encounter, and communicate the management plan with the patient, care partner, and referring clinician. 9 For initial assessments involving a differential diagnosis and management plan, a written clinic visit summary provided to the patient may be helpful. Disclosure of a diagnosis using telemedicine can be especially chal- To protect patient privacy and confidentiality, it is imperative to use encrypted, password-protected videoconferencing software that meets Health Insurance Portability and Accountability Act (HIPAA) requirements. 9 The platform should be universally compatible across devices (e.g., tablets, smartphones, and computers) and user-friendly with minimal preparatory steps for the patient. Encrypted platforms exist that are for-profit (e.g., Zoom Healthcare, Reacts, Cisco Webex Meetings, Medesync, Microsoft Teams, Doxy.me, Vidyo) or opensource and in the public domain (e.g., Jitsi). Patient and clinician internet connectivity can be checked with an internet speed test to ensure that there is adequate bandwidth (e.g., 384 Kbps in both downlink and uplink directions) 15 to reduce potential frustration from connectivity issues and to enhance detection of involuntary movements such as tremor. Confirmation that the patient has sufficient audiovisual input and access to glasses and hearing aids is essential, as perceptual difficulties and slower internet speeds have been linked to lower test scores in videoconferenced environments. 15 History from an informant is essential to a thorough and reliable cognitive assessment, given the role of anosognosia. Consistent with the recent Fifth Canadian Consensus Conference on Diagnosis and Treatment of Dementia (CCCDTD5) recommendations, cognitive assessments include information on cognition, function, and behavior, and fundamentally both patient or care partner are required as sources of information. 16 With the patient's consent, history can be obtained by phone from an informant located in a separate, private space or during a separate appointment. Family members at a third remote site can be included in counseling and history taking. In setting up the encounter, clinician and patient rooms should be quiet and private, with no backlighting or orientation prompts such as calendars. Screenshare options allow presentation of high-resolution visual stimuli (i.e., PDF copies of testing materials) during the remote cognitive assessment. Patient's written responses (e.g., cube copy) can be held up to the camera and documented via screen capture. The patient's face should be positioned close to the webcam so as to help create a sense of natural eye contact. It is important to have a back-up plan if technical difficulties (e.g., continue via telephone) or the need for in-person assessment arise. 17 If audio fails in the setting of preserved video, a combined approach of using the telephone for audio and the tablet, smartphone, or computer for video may be considered. If this is done, the sound on the videoconference device must be muted on both sides to avoid an echo. It is critical to obtain a telephone number prior to the telemedicine encounter as a back-up method of communication in the case of technical failures. 18 The American Psychological Association provides a helpful checklist for setup of telemedicine encounters. The same principles apply for telehealth as they do for in-person testing 19 : Instruments should be easy to administer and acceptable to both the patient and family members. Ideally, instruments should be valid and reliable, measure change over time, and not be biased by language, sensorimotor limitations, education, or culture. 20 A report by the American Academy of Neurology Behavioral Neurology Section Workgroup in 2015 described the neurobehavioral status exam (NBSE). 21 The NBSE is a battery of domain-specific cognitive tests that assess attention, executive function, language, memory, visuospatial functioning, and social cognition to be used in combination with a general neurologic examination, with the goals of facilitating diagnosis and guiding management. The cornerstone of the NBSE is a careful history including the chronology, character, and progression of cognitive, affective, behavioral and constitutional symptoms, functional status, and relevant medical history. Consequently, clinical diagnosis should be guided by the pattern of clinical findings rather than hinging on isolated tests. Incisive clinical judgment is required to ensure that diagnosis is based on converging evidence from the history, cognitive testing, affective, functional, and behavioral assessments, and the general neurological examination. Relatedly, adopting a 'dashboard frame- 23 The broader general concern with a telehealth approach, however, is a reduction in specificity of the cognitive assessment instruments, compared to face-to-face testing. Most current work in the field of videoconferenced neuropsychological testing has focused on feasibility of administration. Although studies to date suggest that videoconference administration of some neuropsychological assessments is feasible and acceptable, 23 Among several telephone-based cognitive assessments, 22 the best known and most validated telephone cognitive test is the Telephone Interview for Cognitive Status (TICS). 26 The TICS takes under 10 minutes to administer, and assesses orientation, attention, short-term memory, sentence repetition, immediate recall, naming to verbal description, word opposites, and praxis; the modified TICS (TICSm) also includes delayed verbal recall. 22 Other approaches for telephone testing include ultra-brief screens or domain-specific testing as part of a dashboard approach ( Table 1) . The Months Backwards Test (MBT) takes <2 minutes to administer and assesses processing speed, focused and sustained attention, working memory, and executive function. Performance can be assessed according to accuracy and processing speed and can be scored pass/fail or on a 10-point scale. 36 The Trail Making Test (Parts A and B) has been adapted for oral use and may be suitable for telephone or videoconference administration. 37 Other brief options include timed tests of oral fluency for animal names, which assesses semantic knowledge, processing speed, as well as executive function. These are easy to administer, and are minimally biased by language of administration, education, or culture. Letter fluency testing has also been administered via telephone, with results very similar to in-person testing. 38 Auditory responsive naming tests (also known as definition naming) may offer an alternative to the more frequently used visual naming tests, and may be suitable for telephone use. 39 In these tests, modified dictionary descriptions are given as prompts to generate words. Auditory naming may be more sensitive to pathology than visual naming, and associated with executive function, 40 although, to our knowledge, no validations for telephone use have been published. As part of the Successful Aging after Elective Surgery (SAGES) study, 38 a 30-minute composite neuropsychological battery was developed for telephone use, demonstrating excellent correlation and agreement to in-person testing scores. Instruments in this battery addressed a number of domains: episodic memory (Hopkins Verbal Learning Test); attention/short-term memory (digit span forwards and backwards); executive function/language (verbal fluency); executive function/semantic access/language (category fluency); confrontational naming/language (modified BNT with written descriptors and phonemic clues). 38 Videoconference has shown promise for cognitive assessments and offers advantages over telephone assessments, since many assess- is a screening instrument developed for use in a culturally and linguistically diverse population, and is less biased by language, sex, and education than the MMSE. 63 The six items include memory (four-item grocery list with~5-minute recall), visuospatial orientation (body part identification including cross-body), praxis (alternating fist/palm bilaterally), visuo-constructional drawing (cube copying), judgment (imaginary road crossing), and language (animal fluency). 64 The (naming, semantic fluency, expressive), and delayed memory. 52 The RBANS has been validated for telehealth use via high-definition video system with generally high correlations between videoconferenced and face-to-face scores and low differences in mean RBANS index scores between testing conditions. 59 Computerized cognitive testing may also address accessibility issues, but further research is needed to assess its utility in cognitive screening. Caution in implementing computerized cognitive testing is suggested, given that the psychometric quality, standardization, normative data and administration advice of computerized cognitive testing for neurocognitive disorders are lacking. 66 The American Academy of Clinical Neuropsychology and the National Academy of Neuropsychology have put forth a position paper on the use of computerized neuropsychological assessment devices. 67 Although there are existing tools in the public domain (e.g., NIH toolbox, Test My Brain) with normative data, they lack rigorous validation studies in clinical and telemedicine contexts. Self-, informant-, and clinician-rated standardized scales are available to assess the important constructs affect, behavior, and function for persons with dementia (summarized in Supplementary Table S1). Depression is common in dementia and MCI and is associated with poorer outcomes. 68 Moreover, depression can contribute to cognitive impairment and may be a reversible component of the presenting cognitive complaint. Depressive symptoms can be elicited directly from the patient or from the informant. Caution with self-report of symptoms is important, as 'affective anosognosia' may decrease reliability, resulting in under-reporting of symptoms and necessitating informant reports. One of the most frequently used clinician administered tools for depression is the Geriatric Depression Scale (GDS), which can be administered over telephone or videoconference. 69 However, the GDS is limited by low sensitivity. 70 The Hamilton Depression Rating Scale may serve as a more sensitive clinician-administered alternative. 70 The Cornell Scale for Depression in Dementia (CSDD), which was developed for dementia and incorporates both an interview of the patient and the informant, also has greater sensitivity than the GDS 70 for depression detection, but takes somewhat longer to complete. 71 Brief self-reports of depressive symptoms may also be useful. The Patient Health Questionnaire-9 (PHQ-9) is very well known and simple to com-plete as it mirrors Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria. 72 It has shown utility in memory clinics and correlation with the CSDD. 73 Similarly, anxiety is important to assess in persons with cognitive impairment and can be measured over telephone or videoconference using either clinician administered or self-report measures. A systematic review and meta-analysis of anxiety tools in dementia determined that the most sensitive tool is the Rating Anxiety in Dementia 74 (RAID-based on caregiver and patient interview), while the most specific is the abbreviated Penn State Worry Questionnaire 75 (which has both self-and collateral-rated versions, with the collateral version having greater sensitivity). As neuropsychiatric symptoms (NPS) are core features of the dementia process, 76 The MBI Checklist (MBI-C) 82 is a validated rating scale to capture MBI in non-demented community-dwelling older adults. The MBI-C is completed by an informant (taking~7 to 9 minutes), and uses a 0 to 3 severity scale similar to the NPI-Q. The MBI-C assesses the domains of apathy, mood/anxiety symptoms, agitation/impulse dyscontrol, social behavior, and psychotic symptoms, and has been associated with amyloid positivity in cognitively unimpaired older adults, 83, 84 and with MCI and poorer neuropsychological test performance in patients with Parkinson disease. 84 Thus the MBI-C may have a role in assessing NPS in those with at most mild cognitive impairment. Functional measures of instrumental activities of daily living (IADLs) early on, and basic activities of daily living (BADLs) later in the course of dementia are important to assess disease severity and progression, and to address safety issues. Even in those with only subjective cognitive decline, impaired IADL function is associated with increased dementia risk, 85 and Amsterdam IADL questionnaire, any of which are suitable to capture function in memory clinic patients. 16 The Harvard Automated Phone Task (APT) is a brief, objective, self-administered assessment that is designed to measure early IADL functioning among cognitively normal and persons with MCI. 86 It is important to note that any attempts to measure NPS and function via telehealth all require mechanisms that ensure appropriate patient consent for informant involvement in the assessment process, as well as methods to provide/administer these scales to informants that ensure confidentiality of patient and informant health information. These assessments can be completed before the telemedicine encounter or by the informant in a separate private room during the remote cognitive assessment of the patient with the clinician. A number of issues limit telemedicine implementation. In all cases, an assessment of the videoconferencing readiness of the patient should be completed before deciding to engage in remote dementia care. There are numerous questions that must be addressed. Given these constraints, consciously weighting the clinical interview data more heavily than the videoconferenced assessment data is ethically advised. Ideally, some portion of the remote assessment is completed with tests that have either normative data or adequate evidence of sensitivity and specificity of the tests adapted for remote delivery. If it is necessary to augment this assessment with remotely delivered assessments for which there is inadequate evidence for validity, we recommend triangulation of data from (1) the clinical interview, (2) validated but brief remote testing (e.g. as, cognitive screening and cognitive domain-specific tests, affect and function inventories), and (3) videoconferenced neuropsychological tests and/or remote neurological exam. If all sources converge, one can have greater confidence in the clinical interpretation and diagnosis. Additional research is required to provide evidence-based guidance on utility, validity, efficacy, tolerability, and safety of remote cogni- Innovative approaches are required to address more challenging features of assessments including subtle behavioral features, task engagement, vision and hearing assessment, social cognition, praxis, and body language. Additional research is required for refinement of computerized cognitive testing that may provide metrics such as response speed and consistency, at millisecond levels, that will complement traditional testing administration methods. Virtual reality platforms may eventually provide methods for remote testing, and integrated tools to monitor multiple aspects of behavior (e.g., movement and sleep) that will facilitate remote health care. Given the range of platforms and devices, harmonization of metrics will be required for broad application to patient care. Telemedicine has great potential to expand the ability to provide remote cognitive assessment during the pandemic and beyond. We are grateful for the excellent feedback and assistance with ref- Western Ontario) has received research funding from the Canadian Institutes of Health Research Saskatchewan Health Research Foundation, and Center for Aging and Brain Health Innovation. S.G. has research funding from CIHR, FQRS, NIH, and the Weston Brain Institute. J.D.F. received research funding from Canadian Institutes of Health Research, Crohn's and Colitis Canada; and royalty and distribution fees from MAPI Research Trust Canadian Institutes for Health Research, Brain Canada, Michael J Fox Foundation, University Hospital Foundation Mild cognitive impairment and dementia prevalence: the Atherosclerosis Risk in Communities Neurocognitive Study Health Organization: World Health Organization The magnitude of dementia occurrence in the world Dementia care during COVID-19 Preexisting comobidities predicting severe covid-19 in older adults in the UK biobank community cohort Patient satisfaction with physician-patient communication during telemedicine High-intensity telemedicine reduces emergency department use by older adults with dementia in senior living communities Ethical adoption: a new imperative in the development of technology for dementia Ethical practice in telehealth and telemedicine Telemedicine and doctor-patient communication: an analytical survey of the literature Patient perception of physician empathy in stroke telemedicine The emerging issue of digital empathy A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone Video-Telemedicine in a memory disorders clinic: evaluation and management of rural elders with cognitive impairment Geriatric telepsychiatry: systematic review and policy considerations Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia Practical aspects of telehealth: set-up and preparation for video consultations Development and evaluation of a telehealth videoconferenced support group for rural spouses of individuals diagnosed with atypical early-onset dementias. Dementia Null hypothesis significance testing: a review of an old and continuing controversy Cognitive and neuropsychiatric screening tests in older adults. Mental health and illness of the elderly Improving clinical cognitive testing: report of the AAN Behavioral Neurology Section Workgroup Telephone-based screening tools for mild cognitive impairment and dementia in aging studies: a review of validated instruments Neuropsychological Test Administration by videoconference: a systematic review and metaanalysis Evidence-based practice for telemental health Using TICS and T-MoCA for telephone assessments of vascular cognitive impairment: promising call or put on hold? The telephone interview for cognitive status Validation of the telephone interview for cognitive status-modified in subjects with normal cognition, mild cognitive impairment, or dementia Validity of the telephone interview for cognitive status (TICS) and modified TICS (TICSm) for mild cognitive imparment (MCI) and dementia screening Prevalence and correlates of dementia and mild cognitive impairment classified with different versions of the modified Telephone Interview for Cognitive Status (TICS-m) Sensitivity and specificity of the Montreal Cognitive Assessment Modified for individuals who are visually impaired National Institute of Neurological Disorders and Stroke-Canadian stroke network vascular cognitive impairment harmonization standards Telephone assessment of cognition after transient ischemic attack and stroke: modified telephone interview of cognitive status and telephone Montreal Cognitive Assessment versus face-toface Montreal Cognitive Assessment and neuropsychological battery Montreal Cognitive Assessment 5-minute protocol is a brief, valid, reliable, and feasible cognitive screen for telephone administration Reliability and validity of the Short Portable Mental Status Questionnaire administered by telephone Validation of a short Orientation-Memory-Concentration Test of cognitive impairment Months backward test: a review of its use in clinical studies Mental Alternation Test (MAT): a rapid and valid screening tool for dementia in primary care The SAGES telephone neuropsychological battery: correlation with in-person measures Auditory and visual naming tests: normative and patient data for accuracy, response time, and tip-of-thetongue Auditory responsive naming versus visual confrontation naming in dementia Remote neuropsychological assessment in rural American Indians with and without cognitive impairment Feasibility of telecognitive assessment in dementia Teleneuropsychology: evidence for Video Teleconference-Based Neuropsychological Assessment Validity of teleneuropsychological assessment in older patients with cognitive disorders Telepsychiatry for neurocognitive testing in older rural latino adults Video teleconference-based neurocognitive screening in geropsychiatry A simple test of central processing speed: an extension of the Short Blessed Test Symbol digit modalities test: Western Psychological Services Los Angeles Neuropsychological assessment and telemedicine: a preliminary study examining the reliability of neuropsychology services performed via telecommunication Detecting Everyday Action Deficits in Alzheimer's Disease Using a Nonimmersive Virtual Reality Kitchen Mobile technologies in the early detection of cognitive decline The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity BDAE-3: Boston Diagnostic Aphasia Examination Efficacy of language assessment in Alzheimer's disease: comparing in-person examination and telemedicine Feasibility of neuropsychological testing of older adults via videoconference: implications for assessing the capacity for independent living Can a virtual reality cognitive training application fulfill a dual role? using the virtual supermarket cognitive training application as a screening tool for mild cognitive impairment Role of cognitive and functional performance in the interactions between elderly people with cognitive decline and an avatar on TV Epreuves mnesiques et d'apprentissage: Delachaux et Niestlé Video Teleconference Administration of the repeatable battery for the assessment of neuropsychological status Pictures of facial affect Diagnostic and interventional implications of telemedicine in Alzheimer's disease and mild cognitive impairment: a literature review The reliability of the Montreal Cognitive Assessment using telehealth in a rural setting with veterans The Rowland Universal Dementia Assessment Scale (RUDAS) and the Folstein MMSE in a multicultural cohort of elderly persons The Rowland Universal Dementia Assessment Scale (RUDAS): a multicultural cognitive assessment scale The Rowland Universal Dementia Assessment Scale (RUDAS) as a reliable screening tool for dementia when administered via videoconferencing in elderly post-acute hospital patients Computerized and on-line neuropsychological testing for late-life cognition and neurocognitive disorders: are we there yet? Computerized neuropsychological assessment devices: joint position paper of the American Academy of Clinical Neuropsychology and the National Academy of Neuropsychology A systematic review and metaanalysis for the prevalence of depression in mild cognitive impairment Geriatric Depression Scale (GDS): recent findings and development of a shorter version Depression Case Finding in Individuals with Dementia: a Systematic Review and Meta-Analysis Cornell scale for depression in dementia The PHQ-9: a new depression diagnostic and severity measure Clinical utility of Patient Health Questionnaire-9 (PHQ-9) in memory clinics The development of a valid and reliable scale for rating anxiety in dementia (RAID) Development and validation of the Penn state worry questionnaire The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Validation of the NPI-Q, a brief clinical form of the neuropsychiatric inventory Behavioral pathology in Alzheimer's disease (BEHAVE-AD) rating scale Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohort Time course of neuropsychiatric symptoms and cognitive diagnosis in National Alzheimer's Coordinating Centers volunteers Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment The Mild Behavioral Impairment Checklist (MBI-C): a rating scale for neuropsychiatric symptoms in pre-dementia populations Mild behavioral impairment is associated with β-amyloid but not tau or neurodegeneration in cognitively intact elderly individuals Mild behavioral impairment is linked to worse cognition and brain atrophy in Parkinson disease Is function in instrumental activities of daily living a useful feature in predicting A lzheimer's disease dementia in subjective cognitive decline Measuring instrumental activities of daily living in non-demented elderly: a comparison of the new performance-based Harvard Automated Phone Task with other functional assessments Emory university telehealth neuropsychology development and implementation in response to the COVID-19 pandemic. The Clinical Neuropsychologist The authors have no conflicts of interest to declare.